About the Product

Description


Etopol 100 Capsule contains Etoposide 100 mg, an anticancer medicine widely used in the treatment of various malignant conditions as part of established chemotherapy regimens. It helps in controlling the growth and spread of cancer cells by interfering with DNA synthesis and cell division processes essential for tumor development. The capsule formulation offers a convenient oral treatment option for patients requiring Etoposide therapy under the supervision of an oncology specialist.

Etoposide belongs to the class of topoisomerase II inhibitors and works by disrupting DNA replication and repair mechanisms within rapidly dividing cancer cells. This action leads to cancer cell death and helps slow disease progression. Due to its proven efficacy and established role in oncology practice, Etoposide remains an important component of several cancer treatment protocols used worldwide.

The capsule is commonly prescribed in the management of small cell lung cancer, testicular cancer, lymphomas, leukemias, and certain other malignancies as determined by the treating oncologist. It may be used alone or in combination with other anticancer medicines depending on the specific treatment plan. Regular medical monitoring is essential during therapy to assess treatment response and manage potential adverse effects effectively.

With the growing demand for advanced cancer care and oral chemotherapy options, Etopol 100 Capsule holds strong market potential in the oncology segment. Its established clinical utility, broad therapeutic applications, and consistent demand among healthcare providers make it a valuable product for retailers and distributors. The product offers significant business opportunities and sustainable growth potential within the expanding oncology pharmaceutical market.

Etopol 100 Capsule may cause nausea, vomiting, loss of appetite, hair loss, fatigue, weakness, diarrhea, mouth ulcers, low blood cell counts, and increased susceptibility to infections. Bone marrow suppression, anemia, bleeding tendencies, and allergic reactions may also occur and require medical supervision.

Etopol 100 Capsule is indicated for the treatment of small cell lung cancer, testicular cancer, Hodgkin lymphoma, non-Hodgkin lymphoma, leukemia, and other malignancies as determined by an oncology specialist. It helps control cancer cell growth and forms part of comprehensive chemotherapy treatment regimens.

This medication should be used only under the supervision of a qualified healthcare professional experienced in oncology treatment. Regular monitoring of blood counts, liver function, kidney function, and overall patient health is essential during therapy. Patients should immediately report fever, unusual bleeding, severe fatigue, breathing difficulties, or signs of infection. The prescribed dosage schedule should be followed carefully for optimal therapeutic outcomes.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the capsules in their original packaging and out of reach of children. Do not use after the expiry date or if the packaging is damaged, opened, or shows signs of deterioration.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions